Li‐Xing Feng
- Molecular Biology
- Pharmacology top 10%
- Cancer Research
- Complementary and alternative medicine top 5%
- Epidemiology
- Topics
- Ubiquitin and proteasome pathways (4 papers)Mitochondrial Function and Pathology (3 papers)Ion Transport and Channel Regulation (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Li‐Xing Feng
28 papers receiving 847 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 579
- Pharmacology 148
- Cancer Research 122
- Complementary and alternative medicine 120
- Epidemiology 114
Countries citing papers authored by Li‐Xing Feng
This map shows the geographic impact of Li‐Xing Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐Xing Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐Xing Feng more than expected).
Fields of papers citing papers by Li‐Xing Feng
This network shows the impact of papers produced by Li‐Xing Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐Xing Feng. The network helps show where Li‐Xing Feng may publish in the future.
Co-authorship network of co-authors of Li‐Xing Feng
This figure shows the co-authorship network connecting the top 25 collaborators of Li‐Xing Feng. A scholar is included among the top collaborators of Li‐Xing Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐Xing Feng. Li‐Xing Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 42 | |
| 6 | 60 | |
| 7 | 29 | |
| 8 | 12 | |
| 9 | 24 | |
| 10 | 9 | |
| 11 | 21 | |
| 12 | 24 | |
| 13 | 21 | |
| 14 | 31 | |
| 15 | 10 | |
| 16 | 15 | |
| 17 | 50 | |
| 18 | 172 | |
| 19 | 37 | |
| 20 | 85 |
About Li‐Xing Feng
Li‐Xing Feng is a scholar working on Complementary and alternative medicine, Molecular Biology and Pharmacology, having authored 30 papers that have together received 854 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Mitochondrial Function and Pathology (3 papers) and Ion Transport and Channel Regulation (3 papers). The work is most often cited by research in Complementary and alternative medicine (120 citations), Toxicology (32 citations) and Pharmacology (148 citations). Li‐Xing Feng has collaborated with scholars based in China and United States. Frequent co-authors include Baohong Jiang, Min Yang, Wanying Wu, De‐an Guo, Shuhong Guan, Xiongwen Zhang, Xuan Liu, Qing‐Xi Yue, Xuan Liu and Xiaofan Gu. Their work appears in journals such as PLoS ONE, European Journal of Pharmacology and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.